geographicatrophy,OcularSurgeryNews,Ophthalmology

Mashup Score: 0

Aviceda raises $207.5 million in Series C funding to advance geographic atrophy program - 2 day(s) ago

Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in geographic atrophy, according to a press release.

Source: www.healio.com

Categories: General Medicine News, Ophthalmology

Tweet Tweets with this article
- Healio_OSN
  
  ❗ICYMI❗ Aviceda Therapeutics secured $207.5 million in Series C financing to advance the AVD-104 program in #geographicatrophy. #OcularSurgeryNews #Ophthalmology https://t.co/AuV0xy4bwn https://t.co/jkDPmLEfrS